Experimental Pathology Laboratories, Inc. Announces a Strategic Alliance with Quality Scientific Solutions, LLC

Experimental Pathology Laboratories, Inc. (EPL) announces a new strategic alliance with Quality Scientific Solutions, LLC (QS3). This alliance is targeted to provide EPL’s preclinical pathology expertise as an important resource to QS3.

About Quality Scientific Solutions
Quality Scientific Solutions, LLC is a research and consulting company dedicated to helping clients create products that meet the highest standard of safety and utility. The six principals of QS3, Drs. Charles Breckenridge, Ralph Cooper, Bob Handa, Peter Hertl, Tony Plant, and Jim Simpkins, have more than 200 years of combined research experience and more than 1,000 publications from studies conducted while in key positions at leading universities, governmental agencies, and industry.

QS3 are specialists in mode and mechanisms of action of chemicals and assessing their environmental transport, fate, and effects. QS3 offers expertise in the following areas: Neuroendocrinology, neuroanatomy, neurodegenerative disease, connectomics, cell physiology, reproduction and development, toxicology, pharmacology, metabolism, kinetics, risk assessment, and environmental sciences.

For more information on QS3’s services, please contact Dr. Charles Breckenridge, Principal and General Manager.

About EPL
Founded in 1971, Experimental Pathology Laboratories, Inc. is a private, employee-owned U.S. company that is recognized internationally for its ability to meet the needs of the scientific community and the challenges of preclinical safety testing with high quality, on-time histopathology services. Valued for its objectivity and responsiveness, EPL has become industry’s and government’s premier source for expert toxicologic pathology evaluation and consultation.